Chronic urticaria treatment guidelines. Aug 8, 2022 · Urticaria is a hetero...
Chronic urticaria treatment guidelines. Aug 8, 2022 · Urticaria is a heterogeneous inflammatory disorder that can be acute or chronic and is defined by the appearance of wheals, angioedema, or both. The presence of angioedema warrants closer monitoring, as it is associated with lower remission rates and treatment resistance 2, 5. Chronic urticaria is classified as spontaneous (without definite triggers) and inducible (with definite and subtype-specific triggers; eg, cold or pressure). c Other therapies with limited evidence (eg, leukotriene Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with itchy wheals, angio-oedema, or both. The guideline presents diagnostic algorithm for chronic urticaria and recommends a limited workup rather than more extensive diagnostic screening tests. 4 days ago · The Chronic Spontaneous Urticaria Pipeline Report delivers a comprehensive disease overview, pipeline analysis, and therapeutic evaluation of the most important drug candidates in development. b Option for severe, treatment-refractory CSU, particularly type IIb autoimmune CSU. Sep 4, 2025 · A recent clinical management review on chronic spontaneous urticaria (CSU) highlighted ongoing challenges in optimizing treatment due to variable triggers, heterogeneous treatment responses, and limited data for special populations. Very recently, the newest update and revision of the international European Academy of Allergy and Clinical Immunology/Global Allergy and Asthma European Network/European Dermatology Forum/Asia Pacific Association of Allergy Asthma Clinical Immunology Treatment algorithm for chronic spontaneous urticaria, modified based on current clinical guidelines. The median number of days from submission to first decision (desk accept or send the paper to review or desk reject). ygh jmy mwfva oppd kelx mgexn bcoc xloijbxyt vsxahzd lbfrf
